top of page
Search
Writer's pictureAbacus Research

MarketAxess (MKTX)

We see an opportunity to own a great long term asset that can compound 10%+. We like everything about MKTX, the high quality, low capital intensity, depressed margins, the recent stock weakness, plus the highly likely cyclical rebound.

  • The market is worried on two fronts:

    1. Tradeweb taking share

    2. Fee compression which is driven by cyclical factors-

  • We think both concerns are overdone. Our 2024 EBITDA estimates are 20% above consensus.

  • The challenge has always been valuation, how much should we pay for this sort of asset? After the derating, we think it is easier than it has been.

Potential Upside: $410-$430 (+27%) Sensible Downside: $275 (-18%)


Recent Posts

See All

Salesforce (CRM)

Salesforce is another potential convert to ‘AI beneficiary’, plus there are reasons to be positive on continued margin expansion. The...

댓글


bottom of page